These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 8529334

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of caffeine in plasma and saliva, and the influence of caffeine abstinence on CYP1A2 metrics.
    Perera V, Gross AS, Xu H, McLachlan AJ.
    J Pharm Pharmacol; 2011 Sep; 63(9):1161-8. PubMed ID: 21827488
    [Abstract] [Full Text] [Related]

  • 5. Oral caffeine maintenance potentiates the reinforcing and stimulant subjective effects of intravenous nicotine in cigarette smokers.
    Jones HE, Griffiths RR.
    Psychopharmacology (Berl); 2003 Jan; 165(3):280-90. PubMed ID: 12434259
    [Abstract] [Full Text] [Related]

  • 6. Intravenous nicotine and caffeine: subjective and physiological effects in cocaine abusers.
    Garrett BE, Griffiths RR.
    J Pharmacol Exp Ther; 2001 Feb; 296(2):486-94. PubMed ID: 11160635
    [Abstract] [Full Text] [Related]

  • 7. Caffeine attenuates early post-exercise hypotension in middle-aged subjects.
    Notarius CF, Morris BL, Floras JS.
    Am J Hypertens; 2006 Feb; 19(2):184-8. PubMed ID: 16448890
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effects of paraxanthine and caffeine on sleep, locomotor activity, and body temperature in orexin/ataxin-3 transgenic narcoleptic mice.
    Okuro M, Fujiki N, Kotorii N, Ishimaru Y, Sokoloff P, Nishino S.
    Sleep; 2010 Jul; 33(7):930-42. PubMed ID: 20614853
    [Abstract] [Full Text] [Related]

  • 10. Psychostimulant pharmacological profile of paraxanthine, the main metabolite of caffeine in humans.
    Orrú M, Guitart X, Karcz-Kubicha M, Solinas M, Justinova Z, Barodia SK, Zanoveli J, Cortes A, Lluis C, Casado V, Moeller FG, Ferré S.
    Neuropharmacology; 2013 Apr; 67():476-84. PubMed ID: 23261866
    [Abstract] [Full Text] [Related]

  • 11. Timing of caffeine's impact on autonomic and central nervous system measures: clarification of arousal effects.
    Barry RJ, Clarke AR, Johnstone SJ, Rushby JA.
    Biol Psychol; 2008 Mar; 77(3):304-16. PubMed ID: 18093716
    [Abstract] [Full Text] [Related]

  • 12. Dissociation of augmented physiological, hormonal and cognitive responses to hypoglycaemia with sustained caffeine use.
    Watson JM, Sherwin RS, Deary IJ, Scott L, Kerr D.
    Clin Sci (Lond); 2003 Apr; 104(4):447-54. PubMed ID: 12653691
    [Abstract] [Full Text] [Related]

  • 13. Pharmacology of ephedra alkaloids and caffeine after single-dose dietary supplement use.
    Haller CA, Jacob P, Benowitz NL.
    Clin Pharmacol Ther; 2002 Jun; 71(6):421-32. PubMed ID: 12087345
    [Abstract] [Full Text] [Related]

  • 14. Antagonism of the cardiovascular effects of adenosine by caffeine or 8-(p-sulfophenyl)theophylline.
    Evoniuk G, von Borstel RW, Wurtman RJ.
    J Pharmacol Exp Ther; 1987 Feb; 240(2):428-32. PubMed ID: 3806407
    [Abstract] [Full Text] [Related]

  • 15. Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients.
    de Champlain J, Karas M, Nguyen P, Cartier P, Wistaff R, Toal CB, Nadeau R, Larochelle P.
    J Hypertens; 1998 Nov; 16(11):1357-69. PubMed ID: 9856375
    [Abstract] [Full Text] [Related]

  • 16. Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients.
    de Champlain J, Karas M, Nguyen P, Cartier P, Wistaff R, Toal CB, Nadeau R, Larochelle P.
    J Hypertens; 1998 Sep; 16(9):1357-69. PubMed ID: 9746123
    [Abstract] [Full Text] [Related]

  • 17. Effect of paraxanthine on FFA mobilization after intravenous caffeine administration in humans.
    Hetzler RK, Knowlton RG, Somani SM, Brown DD, Perkins RM.
    J Appl Physiol (1985); 1990 Jan; 68(1):44-7. PubMed ID: 2312486
    [Abstract] [Full Text] [Related]

  • 18. Paraxanthine/caffeine ratio: as an index for CYP1A2 activity in polycyclic aromatic hydrocarbons exposed subjects.
    Wittayalertpanya S, Hinsui Y, Lawanprasert S.
    J Med Assoc Thai; 2003 Jun; 86 Suppl 2():S310-7. PubMed ID: 12930004
    [Abstract] [Full Text] [Related]

  • 19. Hemodynamic effects of dietary caffeine, sleep restriction, and laboratory stress.
    James JE, Gregg ME.
    Psychophysiology; 2004 Nov; 41(6):914-23. PubMed ID: 15563344
    [Abstract] [Full Text] [Related]

  • 20. [Study of the cardiovascular properties of some new methyl-xanthine derivatives].
    Profire L, Dănilă G, Nechifor M.
    Rev Med Chir Soc Med Nat Iasi; 2003 Nov; 107(4):872-6. PubMed ID: 14756037
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.